The importance of dose and proliferation of SV40-transformed cells with different oncogenic potentials to the level of tumor immunity.
D000818:Animals; D000951:Antigens, Neoplasm; D002455:Cell Division; D002460:Cell Line; D002471:Cell Transformation, Neoplastic / Q000528:radiation effects*; D002478:Cells, Cultured / Q000528:radiation effects; D002999:Clone Cells; D003470:Culture Media; D004622:Embryo, Mammalian; D006649:Histocompatibility Antigens; D007111:Immunity, Cellular; D007114:Immunization; D007165:Immunosuppression Therapy; D008297:Male; D051379:Mice; D008808:Mice, Inbred CBA; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000276:immunology* / Q000473:pathology / Q000601:surgery; D011830:Radiation Effects; D013539:Simian virus 40 / Q000276:immunology*; D013997:Time Factors; D014184:Transplantation, Homologous
D000951:Antigens, Neoplasm; D003470:Culture Media; D006649:Histocompatibility Antigens